Clareo Health | High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine
High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients will be included who fulfil the ICHD-3 criteria \[8\] for HFEM, code 1.3-Chronic Migraine (characteristics similar to CM but with a frequency of 8-14 migraine days per month) with stable therapy in the 3 months prior to the start of Mindfulness treatment. If the therapy is changed during the screening visit, the patient will wait 3 months before starting Mindfulness treatment.
You may not be if
in the presence of psychiatric comorbidities in the psychotic area, reported in the history or assessed by the clinician
if pregnant
in the presence of secondary headache comorbidities (e.g. idiopathic intracranial hypertension)
if they have undergone symptomatic abuse detoxification at least twice in the previous two years
if they have already undergone any kind of treatment with Mindfulness or meditation techniques
